Re: USA ZHCLF investors
in response to
by
posted on
Nov 02, 2022 10:18PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
tada - Anyway, Zenith has no loan and when they did have the Newsoara loan before they paid it off, it was unsecured.